FIELD: medicine. SUBSTANCE: method deals with developing a composition for extracorporal treatment of biological liquids which contain magnetocontrolled sorbent and biocompatible liquid and, additionally, an anticoagulant at the following ratio of components: magnetocontrolled sorbent - 0.1-10.0; anticoagulant - 0.001-1.0; biocompatible liquid - the rest. At the same time magnetocontrolled sorbent contains a ferromagnetic nucleus covered with a single or double-layer membrane. EFFECT: higher efficiency of extracorporal treatment due to development of selective sorbent with target properties. 29 cl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MAGNET-GOVERNED SORBENT AND A METHOD FOR MANUFACTURE THEREOF | 2003 |
|
RU2255800C1 |
| METHOD OF PRODUCING MAGNETIC-OPERABLE COMPOSITE FOR BIOMEDICAL AIMS | 1996 |
|
RU2109522C1 |
| SYSTEM FOR CORRECTING BIOLOGICAL FLUID | 2003 |
|
RU2252037C1 |
| APPLICATION OF LIQUID CRYSTALS AS MEDICAL PRODUCTS | 2008 |
|
RU2385153C1 |
| APPLICATION OF NAPHTHALENE DERIVATIVE AS ONCOLOGICAL DISEASE TREATMENT MEDICINE | 2007 |
|
RU2349311C1 |
| METHOD FOR PURIFYING BLOOD EXTRACORPOTEAL SYSTEM | 1991 |
|
RU2008929C1 |
| RECOMBINANT VACCINE PREPARATION OF PROLONGED ACTION FOR PREVENTION OF PLAGUE IN MAMMALS AND HUMANS AND METHOD OF PREPARATION THEREOF | 2015 |
|
RU2671525C2 |
| METHOD OF OBTAINING OF BIOLOGICALLY ACTIVE PREPARATION (VERSIONS) AND BIOLOGICALLY ACTIVE PREPARATION | 2006 |
|
RU2343929C2 |
| MAGNETICALLY CONTROLLED SORBENT FOR ENDO- AND EXOTOXIN ELIMINATION IN HUMANS | 2013 |
|
RU2516961C1 |
| APPLICATION OF ORGANIC DYES AS MEANS FOR TREATMENT OF ONCOLOGICAL DISEASES | 2007 |
|
RU2354384C1 |
